The Role of Misinformation and Stigma in Opioid Use Disorder Treatment Uptake COMMENT

被引:14
|
作者
Garett, Renee [1 ]
Young, Sean D. [2 ,3 ]
机构
[1] ElevateU, Irvine, CA USA
[2] Univ Calif Irvine, Dept Emergency Med, 333 City Blvd West,Suite 640, Irvine, CA 92868 USA
[3] Univ Calif Irvine, Univ Calif Inst Predict Technol, Dept Informat, Irvine, CA 92868 USA
关键词
Misconception; misinformation; opioid use disorder; stigma; treatment; HEALTH;
D O I
10.1080/10826084.2022.2079133
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Deaths due to opioid overdose continue to rise in the United States. Despite availability of effective treatment for opioid use disorder, uptake is low among those who misuse opioids. Methods: This paper explores the role of misconception, stigma, and misinformation in influencing decisions to initiate medications for opioid use disorder among patients and providers. Conclusion: Misinformation about opioids has been prevalent among future healthcare providers and first responders as well as pharmaceutical companies, which may have implications for treatment. Among individuals with opioid use disorder, treatment uptake and adherence have been negatively affected by misconceptions about treatment efficacy and side effects, as well as stigma. We discuss the role of social media, education, and the community, in mitigating misinformation and addressing misconceptions about opioids and treatment options.
引用
收藏
页码:1332 / 1336
页数:5
相关论文
共 50 条
  • [21] Stigma and Medication for Opioid Use Disorder (MOUD) Among Women
    Jessica L. Chou
    Rikki Patton
    Shannon Cooper-Sadlo
    Carsen Swan
    David S. Bennett
    Dara McDowell
    Asif Zaarur
    Barbara Schindler
    International Journal of Mental Health and Addiction, 2022, 20 : 3262 - 3273
  • [22] Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis
    Couch, Jessica V.
    Whitcomb, Mackenzie
    Buchheit, Bradley M.
    Dorr, David A.
    Malinoski, Darren J.
    Korthuis, P. Todd
    Ono, Sarah S.
    Levander, Ximena A.
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [23] Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians
    Riedel, Lauren
    Uscher-Pines, Lori
    Mehrotra, Ateev
    Busch, Alisa B.
    Barnett, Michael L.
    Raja, Pushpa
    Huskamp, Haiden A.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 228
  • [24] The role of NPs in medication-assisted treatment for opioid use disorder
    Cotton, Brandi Parker
    Ferszt, Ginette G.
    NURSE PRACTITIONER, 2018, 43 (05): : 8 - 8
  • [25] The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder
    Gordon, Adam J.
    Jenkins, Jennifer A.
    SUBSTANCE ABUSE, 2015, 36 (02) : 127 - 128
  • [26] Understanding the role of financial capacity in the delivery of opioid use disorder treatment
    Erick G. Guerrero
    Hortensia Amaro
    Yinfei Kong
    Tenie Khachikian
    Jeanne C. Marsh
    BMC Health Services Research, 23
  • [27] Understanding the role of financial capacity in the delivery of opioid use disorder treatment
    Guerrero, Erick G.
    Amaro, Hortensia
    Kong, Yinfei
    Khachikian, Tenie
    Marsh, Jeanne C.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [28] The Use of Oxytocin for the Treatment of Opioid Use Disorder
    Edinoff, Amber N.
    Sall, Saveen
    Honore, Lauryn G.
    Dies, Ross M.
    Zaheri, Alexa R.
    Kataria, Saurabh
    Jackson, Eric D.
    Shekoohi, Sahar
    Cornett, Elyse M.
    Murnane, Kevin S.
    Kaye, Adam M.
    Kaye, Alan D.
    CURRENT PAIN AND HEADACHE REPORTS, 2023, 27 (5) : 89 - 97
  • [29] The Use of Oxytocin for the Treatment of Opioid Use Disorder
    Amber N. Edinoff
    Saveen Sall
    Lauryn G. Honore
    Ross M. Dies
    Alexa R. Zaheri
    Saurabh Kataria
    Eric D. Jackson
    Sahar Shekoohi
    Elyse M. Cornett
    Kevin S. Murnane
    Adam M. Kaye
    Alan D. Kaye
    Current Pain and Headache Reports, 2023, 27 : 89 - 97
  • [30] Pharmacogenetics of Opioid Use Disorder Treatment
    Richard C. Crist
    Toni-Kim Clarke
    Wade H. Berrettini
    CNS Drugs, 2018, 32 : 305 - 320